Functional phosphines. Part XIV. Cationic (P,N)2-coordinated hydrides of iridium(III): catalysts for CO hydrogenation or transfer hydrogenation?

Treatment of trans-[IrCl(CO)(PPh₃)₂] with Ph₂PCH₂CH₂NH₂ in refluxing para-xylene gave (OC-6-43)-[Ir(H)(Cl)(Ph₂PCH₂CH₂NH₂)₂]Cl (1) which interacted with K[BH(s-Bu₃)] to produce a mixture of (OC-6-22)-[IrH₂(Ph₂PCH₂CH₂NH₂)₂]Cl (2a) and (OC-6-32)-[Ir(H)(Cl)(Ph₂PCH₂CH₂NH₂)₂]Cl (2b). The trans-dihydride 2a was isolated in pure form from the reaction between 1 and KOH/i-PrOH. Different from its isoelectronic (P,N)₂-coordinated Ru^II analogues, the cationic chloro hydrido complex 1 does not act as a catalyst for the direct hydrogenation of acetophenone by molecular H₂, if activated by strong alkoxide base, but rather catalyzes the transfer hydrogenation of the CO bond with methanol or isopropanol as proton/hydride sources. Dihydrido complex 2a is ascribed the role of the actual catalyst as it supports the transfer hydrogenation reaction even in the absence of base. The crystal structure of the addition compound 1 · 2EtOH has been determined.     

Syntheses and structural characterizations of novel mono- and dinuclear iridium hydrido complexes with polydentate nitrogen donor ligands

New five mono- and dinuclear Ir hydrido complexes with polydentate nitrogen ligands, [Ir(H)₂(PPh₃)₂(tptz)]PF₆ (1), [Ir₂(H)₄(PPh₃)₄(tptz)](PF₆)₂ · 2H₂O (2 · 2H₂O), [Ir(H)₂(PPh₃)₂(tppz)]BF₄ (3), [Ir₂(H)₄(PPh₃)₄(tppz)](BF₄)₂ (4) and [Ir₂(H)₄(PPh₃)₄(bted)](BF₄)₂ · 6CHCl₃ (5 · 6CHCl₃), were systematically prepared by the reactions of the precursor Ir hydrido complex [Ir(H)₂(PPh₃)₂(Me₂CO)₂]X (X=PF₆ and BF₄) with 2,4,6-tris(2-pyridyl)-1,3,5-triazine (tptz), 2,3,5,6-tetrakis(2-pyridyl)pyrazine (tppz) and 1,4-bis(2,2^′:6^′,2″-terpyridine-4^′-yl)benzene (bted), and their structures and properties were characterized in the solid state and in solution. Each of the Ir hydrido complexes with polydentate nitrogen ligands crystallographically described a unique coordination mode. Their ¹H NMR spectra demonstrated unusual ¹H NMR chemical shifts of pyridyl rings that are likely induced by the ring current effect of neighboring ligands.     

The reactions of 2-hydroxypyridine ligands with Re2Cl4(μ-dppm)2 (dppm=Ph2PCH2PPh2) that lead to 2-pyridonate complexes

2-Hydroxypyridine (Hhp), 2-hydroxynicotinic acid (HnicOH) and 6-hydroxypicolinic acid (HpicOH) react with Re₂Cl₄(μ-dppm)₂ (dppm=Ph₂PCH₂PPh₂) to afford the complexes Re₂(η²-hp)Cl₃(μ-dppm)₂ (1), Re₂(η²-HnicO)Cl₃(μ-dppm)₂ (2) and Re₂(μ-picO)₂(μ-dppm)₂ (3). The identities of 1 and 2 have been established by single-crystal X-ray structure determinations (Re-Re distances of 2.2602(3) and 2.2539(3) Å, respectively) and they are shown to have unsymmetrical structures with staggered rotational geometries and trans, cis coordination of the pair of μ-dppm ligands. The crystal of 2 that was used in the structure determination was found to be of composition 2Re₂(η²-HnicO)Cl₃(μ-dppm)₂ · Re₂Cl₆(μ-dppm)₂ · 2.906CH₂Cl₂. The structure of Re₂Cl₆(μ-dppm)₂ in this crystal is compared with structures reported in the literature for other crystals that contain this edge-sharing bioctahedral dirhenium(III) complex.     

Copper(II) complexes of new pentadentate bis(benzimidazolyl)-dithioether ligands: synthesis, structure, spectra and redox properties

Copper(II) complexes of a series of linear pentadentate ligands containing two benzimidazoles, two thioether sulfurs and a amine nitrogen, viz. N,N^′-bis{4^′-(2″-benzimidazolyl)(methyl)-3^′-thiabutyl}amine(L¹), N,N^′-bis{4^′-(2″-benzimidazolyl)(methyl)-3^′-thiabutyl}N-methylamine (L²), 2,6-bis{4^′-(2″-benzimidazolyl)(methyl)-3^′-thiabutyl}pyridine(L³), N,N^′-bis{4^′-(2″-benzimidazolyl)-2^′-thiabutyl}amine (L⁴), N,N^′-bis{4^′-(2″-benzimidazolyl)-2^′-thiabutyl}N-methylamine (L⁵) and 2,6-bis{4^′-(2″-benzimidazolyl)-2^′-thiabutyl}-3pyridine (L⁶) have been isolated and characterized by electronic absorption and EPR spectroscopy and cyclic and differential pulse voltammetry. Of these complexes, [Cu(L¹)](BF₄)₂ (1) and [Cu(L²)](BF₄)₂ (4) have been structurally characterized by X-ray crystallography. The coordination geometries around copper(II) in 1 and 4 are described as trigonal bipyramidal distorted square based pyramidal geometry (TBDSBP). The distorted CuN₃S basal plane in them is comprised of amine nitrogen, one thioether sulphur and two benzimidazole nitrogens and the other thioether sulfur is axially coordinated. The ligand field spectra of all the complexes are consistent with a mostly square-based geometry in solution. The EPR spectra of complexes [Cu(L¹)](BF₄)₂ (1), [Cu(L¹)](NO₃)₂ (2), [Cu(L²)](BF₄)₂ (4) and [Cu(L³)](ClO₄)₂ (6) are consistent with two species indicating the dissociation/disproportionation of the complex species in solution. All the complexes exhibit an intense CT band in the range 305-395 nm and show a quasireversible to irreversible Cu^II/Cu^I redox process with relatively positive E_1/2 values, which are consistent with the presence of two-coordinated thioether groups. The addition of N-methylimidazole (mim) replaces the coordinated thioether ligands in solution, as revealed from the negative shift (222-403 mV) in the Cu^II/Cu^I redox potential. The present study reveals that the effect of incorporating an amine nitrogen donor into CuN₂S₂ complexes is to generate an axial copper(II)-thioether coordination and also to enforce lesser trigonality on the copper(II) coordination geometry.     

Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands

All ligands of the epidermal growth factor receptor (EGFR), which has important roles in development and disease, are released from the membrane by proteases. In several instances, ectodomain release is critical for activation of EGFR ligands, highlighting the importance of identifying EGFR ligand sheddases. Here, we uncovered the sheddases for six EGFR ligands using mouse embryonic cells lacking candidate-releasing enzymes (a disintegrin and metalloprotease [ADAM] 9, 10, 12, 15, 17, and 19). ADAM10 emerged as the main sheddase of EGF and betacellulin, and ADAM17 as the major convertase of epiregulin, transforming growth factor alpha, amphiregulin, and heparin-binding EGF-like growth factor in these cells. Analysis of adam9/12/15/17-/- knockout mice corroborated the essential role of adam17-/- in activating the EGFR in vivo. This comprehensive evaluation of EGFR ligand shedding in a defined experimental system demonstrates that ADAMs have critical roles in releasing all EGFR ligands tested here. Identification of EGFR ligand sheddases is a crucial step toward understanding the mechanism underlying ectodomain release, and has implications for designing novel inhibitors of EGFR-dependent tumors.     

Crystallographic study of inhibitors of tRNA-guanine transglycosylase suggests a new structure-based pharmacophore for virtual screening

The enzyme tRNA-guanine transglycosylase (TGT) is involved in the pathogenicity of Shigellae. As the crystal structure of this protein is known, it is a putative target for the structure-based design of inhibitors. Here we report a crystallographic study of several new ligands exhibiting a 2,6-diamino-3H-quinazolin-4-one scaffold, which has been shown recently to be a promising template for TGT-inhibitors. Crystal structure analysis of these complexes has revealed an unexpected movement of the side-chain of Asp102. A detailed analysis of the water network disrupted by this rotation has lead to the derivation of a new composite pharmacophore. A virtual screening has been performed based on this pharmacophore hypothesis and several new inhibitors of micromolar binding affinity with new skeletons have been discovered.     

Unveiling novel 2-cyclopropyl-3-ethynyl-4-(4-fluorophenyl)quinolines as GPCR ligands via PI3-kinase/PAR-1 antagonism and platelet aggregation valuations; development of a new class of anticancer drugs with thrombolytic effects

In the present study, novel 2-cyclopropyl-3-ethynyl-4-(4-fluorophenyl) quinolines (4a-l) were recognized and evaluated as G-Protein Coupled Receptor (GPCR) ligands through molecular evaluations. Thrombin mediates adhesion of mast cell, a type of cell abundantly found in connective tissue and releasing histamine and other substances during inflammatory and allergic reactions, through phosphoinositol 3-kinase pathway. With this background, as preliminary, 4a-l are resolute to be potential leads, designated from their effective phosphoinositol 3-kinase (PI3-Kinase) inhibition potentials, best-docked scores, comparative ligand efficiency, and significant structural attributes evaluated by ab initio simulations. Since thrombin is one of the main reason for various cancer invasion in association with PI3Kinase, a thrombolytic potential of the compounds also analyzed. The experimental in vitro studies confirmed the significant enhancement as PI3Kinase inhibitors and appreciable enhancement in MTT assay of breast and skin cancer cell lines. Significantly, acetophenone substituent in the quinoline scaffold could be coherent to note the significant binding affinity to all the evaluated drug targets.     

Synthesis of 3-aza[4.4.3]propellanes with high σ1 receptor affinity

In order to obtain rigid σ₁ receptor ligands with defined orientation of pharmacophoric elements, the azapropellane scaffold was chosen. Schmidt rearrangement of propellan-8-ones 6 and 10 provided 3-azapropellan-4-ones 7 and 11. Benzylation of the secondary lactams 7 and 11 followed by LiAlH₄ reduction furnished the azapropellanes 4a and 4c, respectively. A second hydrophobic element was introduced by transformation of the alcohols 4a into carbamates 4b. The σ₁ affinity of the azapropellanes 4 is strongly dependent on the stereochemistry and the substitution pattern in 12-position. anti-configured azapropellanes anti-4a and anti-4b show higher σ₁ affinity than their syn-configured counterparts syn-4a and syn-4b. Conversion of the alcohol anti-4a into the carbamate anti-4b led to increased σ₁ affinity, but complete removal of the 12-substituent resulted in the highest σ₁ affinity (K_i(4c)?=?17?nM). It can be concluded that the propellane scaffold alone is able to form strong lipophilic interactions and stabilize the ligand–σ₁ receptor complex as does usually the primary hydrophobic region.     

Gene expression signature of human HepG2 cell line

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and is associated with various clinico-pathological characteristics such as genetic mutations and viral infections. Therefore, numerous laboratories look out for identifying always new putative markers for the improvement of HCC diagnosis/prognosis. Many molecular profiling studies investigated gene expression changes related to HCC. HepG2 represents a pure cell line of human liver carcinoma, often used as HCC model due to the absence of viral infection. In this study we compare gene expression profiles associated with HepG2 (as HCC model) and normal hepatocyte cells by microarray technology. Hierarchical cluster analysis of genes evidenced that 2646 genes significantly down-regulated in HepG2 cells compared to hepatocytes whereas a further 3586 genes significantly up-regulated. By using the Ingenuity Pathway Analysis (IPA) program, we have classified the genes that were differently expressed and studied the functional networks correlating these genes in the complete human interactome. Moreover, to confirm the differentially expressed genes as well as the reliability of our microarray data, we performed a quantitative Real time RT-PCR analysis on 9 up-regulated and 11 down-regulated genes, respectively. In conclusion this work i) provides a gene signature of human hepatoma cells showing genes that change their expression as a consequence of liver cancer in the absence of any genetic mutations or viral infection, ii) evidences new differently expressed genes found in our signature compared to previous published studies and iii) suggests some genes on which to focus future studies to understand if they can be used to improve the HCC prognosis/diagnosis.